Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,232
datasets available to search
ShareScore release 0.9.0
Dataset results
2,232 results for “Cancer cell lines”
AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00961415. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
ClinicalTrials.gov study NCT03003468. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01763788. IPD Sharing: YES. Countries: 1. Publications: 1.
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT04129502. IPD Sharing: YES. Countries: 24. Publications: 1.
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02027428. IPD Sharing: Not stated. Countries: 5. Publications: 35.
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
ClinicalTrials.gov study NCT01124864. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
ClinicalTrials.gov study NCT01355497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
ClinicalTrials.gov study NCT00257608. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT00305942. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00326599. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin
ClinicalTrials.gov study NCT00982111. IPD Sharing: YES. Countries: 20. Publications: 1.
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
ClinicalTrials.gov study NCT00678392. IPD Sharing: YES. Countries: 22. Publications: 11.
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01951586. IPD Sharing: Not stated. Countries: 10. Publications: 1.
A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04702880. IPD Sharing: Not stated. Countries: 11. Publications: 1.
M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03631706. IPD Sharing: YES. Countries: 18. Publications: 3.
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00942825. IPD Sharing: NO. Countries: 1. Publications: 5.
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
ClinicalTrials.gov study NCT01317615. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00820755. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer
ClinicalTrials.gov study NCT00585377. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03382912. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.